Wendy Hague — ASN Events

Wendy Hague — ASN Events

Wendy Hague

NHMRC Clinical Trials Centre, NSW, Australia

Presentations this author is a contributor to:

Randomised phase 3 trial of enzalutamide in androgen deprivation therapy with radiation therapy for high risk, clinically localised, prostate cancer: ENZARAD (ANZUP 1303) (#273)

Scott G Williams

Randomised phase 3 trial of enzalutamide in first line androgen deprivation therapy for metastatic prostate cancer: the ANZUP ENZAMET Trial (ANZUP 1304) (#269)